Emerging therapeutic delivery capabilities and challenges utilizing enzyme/protein packaged bacterial vesicles

Area of Science:

• Biotechnology and Nanomedicine
• Drug Delivery Systems

Background:

• Nanoparticle-based therapeutics are crucial for targeted drug delivery of various pharmaceuticals.
• Current nanoparticle classes (dendrimers, lipid-based, polymeric, inorganic) have implementation benefits and drawbacks.

Purpose of the Study:

• To review current nanoparticle classes for drug delivery.
• To introduce bacterial outer membrane vesicles (OMVs) as an emerging therapeutic nanoparticle class.
• To highlight the potential of OMVs for simplified and controlled nanoparticle production.

Main Methods:

• Review of existing literature on nanoparticle drug delivery systems.
• Discussion of the characteristics, benefits, and limitations of current nanoparticle classes.
• Exploration of bacterial outer membrane vesicles as a novel therapeutic platform.
• Overview of molecular biology techniques for OMV modification and production.

Main Results:

• Various nanoparticle types offer distinct advantages and disadvantages for drug delivery.
• Bacterial outer membrane vesicles offer similar therapeutic benefits to traditional nanoparticles.
• OMVs provide a simplified assembly process compared to other nanoparticle classes.
• Molecular biology techniques enable precise control over OMV production and cargo loading.

Conclusions:

• Bacterial outer membrane vesicles represent a promising, simplified approach to nanoparticle therapeutic development.
• Hijacking OMVs allows for controlled synthesis of targeted, protein-packaged nanoparticles by bacteria.
• This technology has the potential to advance targeted drug delivery and disease treatment.